FRONTIER CAPITAL MANAGEMENT CO LLC – Iovance Biotherapeutics, Inc. Transaction History
FRONTIER CAPITAL MANAGEMENT CO LLC portfolio value:
$3.66M
portfolio value
FRONTIER CAPITAL MANAGEMENT CO LLC quarter portfolio value change:
-13.22%
quarter
Iovance Biotherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +20.56% | 65.25K shares | 162K | $9.58 | 382.64K |
| Q2 2022 | share | Decrease | -26.06% | -111.86K shares | -3.64M | $11.04 | 317.38K |
| Q1 2022 | share | Decrease | -20.11% | -108.03K shares | -3.11M | $16.65 | 429.25K |
| Q4 2021 | share | Decrease | -20.63% | -139.64K shares | -6.43M | $19.42 | 537.29K |
| Q3 2021 | share | Decrease | -33.29% | -337.87K shares | -9.71M | $24.66 | 676.94K |
| Q2 2021 | share | Increase | 0.00% | 1.01M shares | 26.40M | $26.02 | 1.01M |